Feasibility of RECIST-based real-world tumor response assessment in metastatic non-small cell lung cancer patients.

e21121Background: Treatment response to anti-cancer therapies for advanced lung cancer is usually assessed according to the Response Evaluation Criteria in Solid Tumors (RECIST), which is not gener...